These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8893184)

  • 1. Uric acid transport in fanconi syndrome with marked renal hypouricemia: analysis using pyrazinamide and benzbromarone.
    Moriwaki Y; Yamamoto T; Takahashi S; Hiroishi K; Yamakita J; Nasako Y; Naito Y; Higashino K
    Nephron; 1996; 74(2):452-3. PubMed ID: 8893184
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperuricosuria in the Fanconi syndrome.
    Meisel AD; Diamond HS
    Am J Med Sci; 1977; 273(1):109-15. PubMed ID: 848505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases in whom pyrazinamide does not inhibit the uricosuric action of benzbromarone.
    Yamamoto T; Moriwaki Y; Takahashi S; Suda M; Agbedana EO; Higashino K
    Nephron; 1992; 61(4):432-4. PubMed ID: 1501741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
    Moriwaki Y; Yamamoto T; Takahashi S; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):84-8. PubMed ID: 2307550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
    Hiroshige K; Takasugi M; Yuu K; Kuroiwa A
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1268-75. PubMed ID: 7853759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of renal hypouricemia with nephrolithiasis.
    Hirasaki S; Koide N; Fujita K; Ogawa H; Tsuji T
    Intern Med; 1997 Mar; 36(3):201-5. PubMed ID: 9144014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypouricemia and cancer. A study of the mechanisms of renal urate wasting in two cases.
    Morales M; García-Nieto V
    Oncology; 1996; 53(4):345-8. PubMed ID: 8692542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary renal hypouricemia in children.
    Takeda E; Kuroda Y; Ito M; Toshima K; Watanabe T; Ito M; Naito E; Yokota I; Hwang TJ; Miyao M
    J Pediatr; 1985 Jul; 107(1):71-4. PubMed ID: 4009341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hypouricemia due to an isolated renal defect of urate transport.
    Hisatome I; Ogino K; Saito M; Miyamoto J; Hasegawa J; Kotake H; Mashiba H; Nakamoto S
    Nephron; 1988; 49(1):81-3. PubMed ID: 3380222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
    Moriwaki Y; Yamamoto T; Takahashi S; Suda M; Agbedana OE; Hada T; Higashino K
    Adv Exp Med Biol; 1991; 309A():151-5. PubMed ID: 1789196
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated defect in postsecretory reabsorption of uric acid.
    Sorensen LB; Levinson DJ
    Ann Rheum Dis; 1980 Apr; 39(2):180-3. PubMed ID: 7387223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on uric acid excretion in patients with hypouricemia].
    Hiroshige K; Yuu K; Takasugi M; Soejima M; Kuroiwa A
    Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):829-34. PubMed ID: 8411762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
    Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
    Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
    Hisatome I; Ogino K; Igawa O; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypouricemia due to renal urate wasting. Two types of tubular transport defect.
    Tofuku Y; Kuroda M; Takeda R
    Nephron; 1982; 30(1):39-44. PubMed ID: 7088231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of exercise-induced acute renal failure in a patient with enhanced renal hypouricaemia.
    Kurihara I; Soma J; Sato H; Ikarashi T; Tsunoda K; Miura R; Suzuki T; Sato M; Furuyama T; Ito S; Saito T
    Nephrol Dial Transplant; 2000 Jan; 15(1):104-6. PubMed ID: 10607777
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of pharmacological effects of uricosuric agents by concomitant treatment with pyrazinamide in rats.
    Taniguchi T; Ashizawa N; Matsumoto K; Iwanaga T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):253-260. PubMed ID: 27933340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
    Roch-Ramel F; Guisan B; Diezi J
    J Pharmacol Exp Ther; 1997 Feb; 280(2):839-45. PubMed ID: 9023298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause of persistent hypouricemia in outpatients.
    Hisatome I; Ogino K; Kotake H; Ishiko R; Saito M; Hasegawa J; Mashiba H; Nakamoto S
    Nephron; 1989; 51(1):13-6. PubMed ID: 2915747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.